The total coronavirus cases mounted to 88,74,290 with 29,163 infections being reported in a day while the death toll climbed to 1,30,519 with 449 new fatalities, the data updated at 8 am showed.
'Unfortunately, during this pandemic, everybody started saying that well, these are desperate times and desperate times need desperate solutions.' 'Purely out of fear, anxiety, panic, this knowledge that people started acquiring from WhatsApp University and social media, it pushed science completely to the backseat.'
'There is no emergency of a third wave that we are rushing for booster doses.'
The Union health ministry said West Bengal and Himachal Pradesh reported a casualty each on Monday, taking the total number of deaths to nine in the country due to COVID-19.
There are worrying signs that the resolve to continue adhering to the dos and don'ts of the times -- physical distancing, wearing masks and maintaining hygiene protocol - is flagging. This recklessness, more evident ahead of Diwali, may lead to a resurgence in novel coronavirus infections and stall the progress in curbing the disease, the experts said.
Given the robust and statute-based death registration system in India, while some cases could go undetected as per the principles of infectious disease and its management, missing out on the deaths is unlikely, the Union health ministry said.
Indian Council of Medical Research Director General Balram Bhargava had on Monday recommended the use of hydroxychloroquine for treating healthcare workers handling suspected or confirmed coronavirus cases.
The stage of alert will be based on positivity rate (on two consecutive days), cumulative number of new cases (over a week) and average oxygenated-bed occupancy (for a week).
The test used now, called PCR (or polymerace chain reaction), uses a nasal or throat swab sample and identifies the virus. These tests take at least five hours to give results. The rapid test, on the other hand, uses a blood sample and gives results based on detecting the presence of certain antibodies that react to the coronavirus protein.
The Supreme Court on Wednesday directed the National Disaster Management Authority (NDMA) to issue fresh guidelines for providing minimum standards of financial help to families of those who lost their lives to COVID-19.
Is the worst of the Covid crisis behind India? As cases dip three weeks after Diwali, the answer is a possible yes, say several experts, attributing the downslide to a large section of the population already exposed to the virus during the second wave and a stepped up vaccination campaign.
'At the stage where we are in today in the country, by the time mass vaccination becomes available, it would be around the middle of next year.' 'Most of those people, who got infected this year, will be next year back to level zero -- once again susceptible.'
The rise in the number of coronavirus cases has gained pace significantly. It took 110 days for the number of cases in the country to reach one lakh but just 53 days more to race past the eight-lakh mark.
A third wave of COVID-19 -- if it occurs -- is unlikely to be as severe as the second wave given the extent of spread of coronavirus infections that has already taken place in the country, according to a study.
'In the coming two-three months, we need to be cautious that there is no upsurge'
The death toll due to COVID-19 climbed to 47,033 with 942 people succumbing to the disease in the last 24 hours, health ministry data updated at 8 am showed.
Is it sustainable?' 'Or is it like an overdose of a medicine that saves your life in the short run but kills you through long-lasting side-effects?' asks Shekhar Gupta.
'Don't panic. Believe in yourself.' 'This is a preventable illness. Only you can prevent it.'
While Yatra is building a digital services platform to offer skill development training and sourcing solutions to corporate, Thomas Cook has partnered ICMR-accredited labs to offer Covid-19 certification, and MakeMyTrip is offering chartered flight services.
The central government has constituted six Inter-Ministerial Central Teams (IMCTs) to make an on-spot assessment of the COVID-19 situation in these places and issue necessary directions to the four states -- Madhya Pradesh, Maharashtra, Rajasthan and West Bengal -- for redress.
A Chennai-based man has demanded a compensation of Rs 5 crore from the SII after his health worsened allegedly after volunteering for the clinical trials for a COVID-19 vaccine.
Ahmedabad was the first stop in the PM's three city tour today, to personally review the vaccine development and manufacturing process in the country.
'Prevention plus vaccination is what is going to take us into better territory by September or October.'
The ministry said this will also ensure early detection, isolation and hospitalisation of such "false" negative cases. It has also been reiterated in the joint letter that while the RAT is being used to increase access and availability of testing in the field, RT-PCR remains the gold standard of COVID tests, the ministry said.
The modalities of COVID-19 vaccine delivery, distribution and administration were discussed during the meeting.
Dr V K Paul, Member (Health) Niti Aayog, who also chairs the national expert group on COVID-19 vaccine administration, said the government attaches 'great importance to this offer of partnership from a very special friend to this nation'.
Modi tweeted that the meeting discussed important issues related to the progress of vaccine development, regulatory approvals and procurement.
The number of active COVID-19 cases stands at 9,272 and as many as 1,189 people have been cured and discharged, and one has migrated, it said.
It will be unfair to put a date for any COVID wave as the behaviour of coronavirus is unpredictable and a disciplined and effective pandemic response can help the country get away from any significant outbreak, COVID Task Force chief V K Paul said.
There are 6,76,514 active cases of coronavirus infection in the country which is 24.45 per cent of the total caseload, while the number of recoveries has surged to 20,37,870.
The country's COVID-19 count includes 6,73,166 active cases, 19,77,780 discharged/migrated patients.
The death toll due to the disease rose to 42,518 with 933 fresh fatalities being reported in a day, data updated at 8 am showed. There are 6,19,088 active cases of COVID-19, comprising 29.64 per cent of the caseload.
The company has set an affordable ceiling price of USD 3 (around Rs 225) per dose, it added.
'Legally, anything can be promised in the manifestos. However, the SC has said the promises should not be unreasonable'
Kerala health minister Veena George, who reviewed the state's COVID-19 situation two days ago, today blamed the violation of home quarantine directives for the worsening situation and cautioned against the increased indoor transmission of coronavirus at homes.
In phase I, the vaccine would be tested on 375 volunteers and the maximum of 100 of them would be from AIIMS.
Poonawalla, during an interaction with Odisha Chief Minister Naveen Patnaik through a video conference, expressed optimism that the COVID-19 vaccine could be ready by October-November this year and the next phase of the trial can start in mid-August in India. According to a press note released by the CMO, Poonawalla has informed that the Oxford University vaccine has shown promising results in the first phase trial.
The novel mRNA vaccine candidate, HGCO19, is supported with seed grant under the Ind-CEPI mission of the Department of Biotechnology. The mRNA vaccines do not use the conventional model to produce immune response. Instead, they carry molecular instructions to make the protein in the body through a synthetic RNA of the virus.
The volunteer said he had also volunteered 10 years ago for clinical trials for a vaccine against the H1N1 (swine flu) virus.
The Corosure Kit has received ICMR approval with the highest score and DCGI approved with a very high sensitivity and specificity.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances